Recent Patents on Anti-Cancer Drug Discovery

Editor-in-Chief

Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Meet Our Editorial Board Member free to download

Volume:13   Issue: 2
Pp: 131-132
Ritu Aneja
DOI: 10.2174/157489281302180511120102
Published on: 11 May, 2018



Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation open access plus

Volume:13   Issue: 2
Pp: 133-144
Juan F. Santibanez* and Suncica Bjelica
DOI: 10.2174/1574892813666180220105958
Published on: 11 May, 2018



PARP Inhibitors in Epithelial Ovarian Cancer open access plus

Volume:13   Issue: 2
Pp: 145-158
Kristin N. Taylor and Ramez N. Eskander*
DOI: 10.2174/1574892813666171204094822
Published on: 11 May, 2018



Advances in the Discovery of Anthraquinone-Based Anticancer Agents

Volume:13   Issue: 2
Pp: 159-183
Alexander S. Tikhomirov*, Alexander A. Shtil and Andrey E. Shchekotikhin
DOI: 10.2174/1574892813666171206123114
Published on: 11 May, 2018



Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins open access plus

Volume:13   Issue: 2
Pp: 184-200
Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*
DOI: 10.2174/1574892812666171129141211
Published on: 11 May, 2018



Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied open access plus

Volume:13   Issue: 2
Pp: 201-208
Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi
DOI: 10.2174/1574892813666180220110729
Published on: 11 May, 2018



Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options open access plus

Volume:13   Issue: 2
Pp: 209-223
Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*
DOI: 10.2174/1574892813666180115151554
Published on: 11 May, 2018



Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies

Volume:13   Issue: 2
Pp: 224-239
Monireh Mohsenzadegan*, Farhad Seif, Mohammad M. Farajollahi and Majid Khoshmirsafa
DOI: 10.2174/1574892813666180213164700
Published on: 11 May, 2018



Anti-Cancer Effect of α-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells

Volume:13   Issue: 2
Pp: 240-247
Xiaofen Ni, Jiajun Chen, Fengying Lu, Zhengzhong Yuan, Xiaofeng Xu, Zhen Hu* and Lei Jiang*
DOI: 10.2174/1574892813666180329163945
Published on: 11 May, 2018



Reduced Lipocalin 2 Expression Contributes to Vincristine Resistance in Human Colon Cancer Cells

Volume:13   Issue: 2
Pp: 248-254
Xiao Guo, Qin Li, Yan-Fang Wang, Tian-Yun Wang*, Si-Jia Chen and Zheng-Wei Tian
DOI: 10.2174/1574892813666171221120504
Published on: 11 May, 2018



Synthesis and DFT Study on Hantzsch Reaction to Produce Asymmetrical Compounds of 1,4-Dihydropyridine Derivatives for P-Glycoprotein Inhibition as Anticancer Agent

Volume:13   Issue: 2
Pp: 255-264
Shirin Mollazadeh, Fatemeh Moosavi, Farzin Hadizadeh*, Mahmoud Seifi, Javad Behravan and Maryam Iman*
DOI: 10.2174/1574892813666180220112613
Published on: 11 May, 2018



Patent Selections promotion: free to download

Volume:13   Issue: 2
Pp: 265-270

DOI: 10.2174/157489281302180511142022
Published on: 11 May, 2018